Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Drug Saf. 2011 Nov 1;34(11):1027-48. doi: 10.2165/11593130-000000000-00000. Review.

PMID:
21981432
2.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
3.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

4.

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.

Alwan S, Friedman JM, Chambers C.

CNS Drugs. 2016 Jun;30(6):499-515. doi: 10.1007/s40263-016-0338-3. Review.

PMID:
27138915
5.

Clinical management of perinatal depression: focus on paroxetine.

Newport DJ, Stowe ZN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:148-66. Review.

PMID:
14566197
6.

Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.

Weisskopf E, Fischer CJ, Bickle Graz M, Morisod Harari M, Tolsa JF, Claris O, Vial Y, Eap CB, Csajka C, Panchaud A.

Expert Opin Drug Saf. 2015 Mar;14(3):413-27. doi: 10.1517/14740338.2015.997708. Epub 2015 Jan 2. Review.

PMID:
25554364
7.

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009286. doi: 10.1002/14651858.CD009286.pub2. Review.

PMID:
23152272
8.

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Gur TL, Kim DR, Epperson CN.

Psychopharmacology (Berl). 2013 Jun;227(4):567-82. doi: 10.1007/s00213-013-3115-8. Epub 2013 May 17. Review.

9.

Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

Gentile S, Bellantuono C.

J Clin Psychiatry. 2009 Mar;70(3):414-22. Epub 2009 Feb 24. Review.

PMID:
19254517
10.

Selective serotonin reuptake inhibitors for depression in pregnancy.

Susser LC, Sansone SA, Hermann AD.

Am J Obstet Gynecol. 2016 Dec;215(6):722-730. doi: 10.1016/j.ajog.2016.07.011. Epub 2016 Jul 16. Review.

PMID:
27430585
11.

The use of selective serotonin reuptake inhibitors in pregnancy.

Wen SW, Walker M.

J Obstet Gynaecol Can. 2004 Sep;26(9):819-22. Review.

PMID:
15361279
12.

Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.

Gentile S.

Expert Opin Drug Metab Toxicol. 2015;11(10):1585-97. doi: 10.1517/17425255.2015.1063614. Epub 2015 Jul 1. Review.

PMID:
26135630
13.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
14.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
15.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
16.

[Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].

Watanabe O.

Seishin Shinkeigaku Zasshi. 2014;116(12):996-1004. Review. Japanese.

PMID:
25823351
17.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
18.

[The safety profile of escitalopram in pregnancy and breastfeeding].

Bellantuono C, Orsolini L, Bozzi F.

Riv Psichiatr. 2013 Nov-Dec;48(6):407-14. doi: 10.1708/1379.15335. Review. Italian.

PMID:
24441517
19.

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ.

Cochrane Database Syst Rev. 2015 Jan 20;1:CD007505. doi: 10.1002/14651858.CD007505.pub2. Review.

PMID:
25601826
20.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181

Supplemental Content

Support Center